一文读懂小儿先天性心脏病的诊断与治疗

2020-09-06 佚名 医谷网

患儿9个月,男性,广东东莞人,因气促1个月,咳嗽3天,加重伴发绀4小时于3月5日12时入院。

患儿9个月,男性,广东东莞人,因气促1个月,咳嗽3天,加重伴发绀4小时于3月5日12时入院。

患儿于1个月前无诱因出现气促,初时气促见于吃完奶时,伴出汗多,休息后好转,家长未予重视。以后在吃奶时也有气促,中间需停歇3-4次(每次5分钟左右)オ吃饱,吃完奶后见满头大汗,间有哭闹,哭闹时气促更明显,但无发绀。多次在当地卫生院治疗仍无改善(具体不详)。3天前受凉后流涕,发热,体温38℃,无寒战、抽搐,有咳嗽,初时干咳,后转为数声咳,有痰声但无痰咳出,气促加重。4小时前哭闹,咳剧,气促明显,伴面色发绀,拒奶。当地医院用PG等药物治疗无好转,体检发现心脏杂音,为进一步诊治来我院

病后吃奶量减少,烦躁,睡眠时易惊醒,近1天哭声低,尿量比平时少1/3,无呕吐、水肿,大便正常,无异物吸入史。既往除3次感冒(服中药好转)外,无发绀、抽搐等病史。

个人史:足月顺产,出生体重3公斤,一直母乳喂养,偶服鱼肝油及钙片。3个月会抬头,8个月出牙及独坐。已做卡介苗、百白破疫苗预防接种,服过小儿麻痹糖丸。母35岁父39岁,母孕2个月时曾发热3天,服中药后痊愈。父母非近亲婚配,均无特殊病史。

体检:T37℃,P170次/分,R68次/分,BP17/7kPa,Wt8kg。发育营养中等,反应一般,哭声低,呼吸浅促,唇及口周轻发绀,余皮肤、粘膜无发绀,无皮疹、出血点、黄染。浅表淋巴结不大,头颅五官无畸形,前囟平软,1×1cm2。巩膜无黄染,瞳孔等大等圆,对光反射存在。乳牙2只,咽充血(+)。颈软,颈静脉充盈,气管居中,甲状腺不大。胸廓无畸形,呼吸运动对称,三凹征(+)。双肺呼吸音粗,可闻及密集中小水泡音。心前区稍隆起,心尖搏动弥散,范围3x3c㎡,无震颤,心界左右扩大,心率170次/分,心律整齐,第一心音稍低,肺动脉瓣区第二心音亢进,有第三心音,于胸骨左缘第3、4肋间可闻全收缩期反流性杂音3°/6°,传导广泛,无心包磨擦音。腹平软,无包块,肝右肋下3cm,质中,边缘钝,肝颈征(+),脾左肋下未及,移动性浊音(-)。脊柱四肢无畸形,下肢无水肿,正常男童外阴,双膝反射存在,未引出病理性神经反射。

实验室检查:血红蛋白120g/L,红细胞4.0×1012/L,白细胞12.0x109/L。分类:中性0.60,淋巴0.40,血小板160×109/L。尿、大便常规正常。肝功能正常。胸片、心电图、彩色超声心动图检查已做,结果未回。

讨论

实习医生A:本例的病情特点:①9个月婴儿;②吃奶时气促1个月,3天前咳嗽、发热,气促加重,4小时前发绀;③母孕2个月时发热3天;④体征:呼吸浅促,哭声低,唇及口周轻发绀,颈静脉充盈,三凹征(+),双肺有密集中小水泡音;心尖搏动弥散,无震颤,心界扩大,心率170次/分,第一心音稍低,第二心音亢进,有第三心音,胸骨左缘第3、4肋间有全收缩期反流性杂音3级,传导广泛;肝肋下3cm,边缘钝,肝颈征(+);⑤血白细胞增高,分类中性增多;肝功正常。根据这些特点,可考虑诊断为:①支气管肺炎合并心力衰竭;②先天性心脏病?

教师:同学对支气管肺炎的掌握不错,但对心脏方面的问题似乎不够清楚或带有疑问。的确,对有心脏杂音的病例,应该排除无害性杂音。一部分婴幼儿可有心脏杂音,但杂音局限、柔和、易变化,多在2°/6°以下,无症状,不影响生长发育,更没有心脏增大,临床称之为无害性杂音。本例的特点已可排除无害性杂音,应是器质性杂音。小于3岁的器质性杂音多为先天性心脏病。本例为9个月婴儿,不单有器质性杂音,而且有气促症状,可诊断为先天性心脏病(简称先心病)。先心病有许多种类,本例属于哪一病种呢?

实习医生B:患儿主要症状为气促,气促前无发绀,气促时也无发绀,近3天合并肺炎、心衰后才出现发绀,首先考虑为左向右分流型也就是潜伏青紫型先心病。目前辅助检查结果未回,等结果回来再进一步诊断。我们已做但未有结果的检查包括胸片、心电图、彩色多普勒超声心动图。

教师:这些辅助检查是需要的,对诊断有重要作用。但我们并非等全部辅助检查结果出来后才下诊断,应该学会临床分析。小儿先心病的心脏听诊是非常重要的,部分病儿可依靠心脏杂音特征做出准确的诊断。根据本例特点,能否进一步诊断呢?

实习医生C:应该可以。左向右分流先心病常见的有室间隔缺损、房间隔缺损及动脉导管未闭,临床症状相似。房间隔缺损的杂音是胸骨左缘第2、3肋间的2到3级收缩期喷射性杂音,传导范围小,肺动脉瓣区第二心音有固定分裂。动脉导管未闭则在胸骨左缘第2肋间有连续性机器样杂音,向颈部传导。本例无连续性杂音及第二心音固定分裂,杂音最响部位又偏低在第3、4肋间,且传导广泛。不支持房间隔缺损及动脉导管未闭,可诊断为室间隔缺损。

实习医生D:不支持动脉导管未闭的还有脉压不大,无大动脉枪击音。诊断仍考虑为室间隔缺损,但为何无震颤?

教师:分析得不错,我同意大家的诊断。房间隔缺损的杂音是由于左房的血通过缺损流入右房再到右室,使右心室排血量增多,引起右室流出道相对狭窄引起的,呈喷射性。动脉导管未闭、室间隔缺损的杂音产生则是血液流经缺损部产生。动脉导管未闭时,不论收缩期或舒张期,血液均由主动脉流向肺动脉,产生连续性杂音。但如肺循环压力高时,可能只会听到收缩期杂音,而不呈连续性。所以除杂音性质外,杂音最响部位也是鉴别方法之一,合并肺动脉高压时更是重要。本例因肺动脉瓣第二音亢进,应该加上可能合并肺动脉高压的诊断。心杂音强弱与病情轻重不一定平衡。杂音响亮病情并非就重,相反,杂音轻或无杂音病情反而可能严重。室间隔缺损杂音与缺损大小、肺血管阻力有关。本例有肺炎、心衰、肺动脉高压,都可影响杂音强度。震颤除与婴儿胸壁皮下脂肪等因素有关外,与杂音强度密切相关。本例婴儿皮下脂肪厚,收缩期杂音3级,可无震颤。

实习医生E:老师,如果超声心动图检查无异常怎么办?

教师:出现这种情况机会较少,超声心动图在先心病检査诊断中起最重要的作用,但也并非100%准确。阴性结果也不能排除先心病,应结合临床及其他检查综合考虑,必要时重做。

实习医生F:老师,彩色超声心动图结果出来了。

教师:谢谢!结果显示左右心室肥大,室间隔缺损1cm,肺动脉高压(中度)。与我们刚才的分析是相符合的。

室间隔缺损是最常见的先心病,其临床表现决定于缺损的大小。小型缺损(小于0.5cm)一般无症状,仅有胸骨左缘第3、4肋间响亮粗糙的全收缩期杂音。中型、大型缺损患儿多有乏力、气促、多汗、消瘦、易发生肺炎及心衰,心界增大,心尖搏动弥漫,胸骨左缘第3、4肋间有3、4级全收缩期杂音,传导广,肺动脉瓣第二心音亢进。肺动脉高压严重时,左向右分流减少甚至出现右向左分流,心杂音减轻,患儿出现青紫。临床上特别重视肺动脉高压情况,若肺动脉高压显着,产生持续性右向左分流,可能为梗阻性肺高压,即Eisenmengre Syndrome,此时已失去手术机会。本例缺损介于中型与大型缺损之间,目前合并有支气管肺炎、心衰、肺动脉高压(中度),应如何处理?

实习医生A:我们已用二联抗生素治疗,并且用强心药西地兰,计划继续抗炎及对症处理?

实习医生G:外科手术修补缺损。

教师:强心及抗感染都是重要的,二者关系相互影响。室间隔缺损病儿肺部充血,合并心衰时肺部淤血,肺充血淤血基础上易发生肺炎。肺部体征为心衰与肺炎所合有。心衰未控制时肺部淤血,单纯用抗生素效果往往不佳。心衰治疗除强心药外,还应选用利尿剂、扩血管药。值得注意的是,与其他心衰治疗不同,应坚持规则、维持用药,防止反复发展为顽固性心衰,也为手术做好准备。

实习医生H:老师,如何掌握手术时机?

教师:单纯室间隔缺损患儿,缺损小者不一定需手术治疗,但应定期复查。中型缺损有症状者,宜于学龄前期做缺损修补术。大型缺损有内科难以控制的心衰,包括反复肺炎和生长迟缓,应及时予手术治疗。6个月至2岁婴幼儿,虽然心衰能控制,但肺动脉压持续升高、大于体循环动脉压的1/2者,亦应及早手术修补缺损。当然,具体病例应具体分析。结合本例,第一次心衰如能控制,肺动脉高压缓解,可不必手术,但需继续使用强心药并定期随访,防止心衰及肺高压再次发生、加重,至学龄前期才考虑手术治疗。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2021-01-11 ms1000000729993584

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-08 huirong
  4. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-07 148c6860m17暂无昵称

    学习啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-07 ms7000000139248197

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-07 1476f000m96暂无昵称

    好的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-07 14818eb4m67暂无昵称

    学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-07 ms2000001665617076

    学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=915433, encodeId=a2fe9154336d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c8a5451670, createdName=ms1000000729993584, createdTime=Mon Jan 11 01:15:24 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719117, encodeId=6e4c1e19117b4, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Fri Apr 23 21:47:50 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369519, encodeId=1069136951985, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue Sep 08 14:47:50 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883439, encodeId=ea8088343957, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/b6f9fd0c92f041fb87d7e5df3981cac6/ebaa3e1fcb174de291f5f06daf872739.jpg, createdBy=dab05329240, createdName=148c6860m17暂无昵称, createdTime=Mon Sep 07 22:40:15 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883341, encodeId=13988833419a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Mon Sep 07 16:10:33 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883252, encodeId=955688325286, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33ee5216569, createdName=1476f000m96暂无昵称, createdTime=Mon Sep 07 08:33:08 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883228, encodeId=1d5e8832283f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Mon Sep 07 08:09:12 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883220, encodeId=5fee883220ce, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82dd5416250, createdName=ms2000001665617076, createdTime=Mon Sep 07 07:37:53 CST 2020, time=2020-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883205, encodeId=8d73883205ba, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K7ZTjFvQibURUwGmevyQCnZbEay4uhhb3ic3icekqV0LJu9rlmO6JmbAibQT7Ld1sPVLBa7VvKUFo3uJ/0, createdBy=77971947351, createdName=凯丽菇凉, createdTime=Mon Sep 07 00:38:50 CST 2020, time=2020-09-07, status=1, ipAttribution=)]
    2020-09-07 凯丽菇凉

    学习

    0

相关资讯

Nano Today:纳米酶前药催化治疗肿瘤新策略

酶学疗法一直是一个非常吸引人的疾病治疗策略,因为酶催化具有高效性和特异性。比如酶激活前药治疗策略,因其高选择性和低毒性,是一种前景广阔的抗癌策略。

Sci Rep:α-硫辛酸的抗过敏性鼻炎活性研究

最近,有研究人员建立了一个卵清蛋白(OVA)诱导的过敏性鼻炎(AR)小鼠模型来调查了是否α-硫辛酸(LA)对上呼吸道炎症具有保护作用。

盘点:近期前列腺癌治疗盘点

【1】Brit J Cancer:使用剪接寡核苷酸靶向ERG致瘤基因来治疗前列腺癌的研究

Eur Arch Otorhinolaryngol:白细胞介素-17A能够上调过敏性鼻炎患者鼻腔成纤维细胞胸腺基质淋巴生成素的产生

新的证据表明白细胞介素(IL)-17A与过敏性鼻炎(AR)的发病机制有关。胸腺基质淋巴生成素(TSLP)协调免疫反应向Th2型发展。尽管在AR中发现TSLP增加,但IL-17A在鼻腔成纤维细胞产生TS

马斯克的脑机接口产品离疾病治疗还有多远

近日,埃隆.马斯克用三只小猪展示了其旗下“神经连接”公司最新的脑机接口产品,引起广泛关注。

盘点:近期鼻炎与治疗盘点

【1】Allergy Asthma Immunol Res:屋尘螨免疫治疗对鼻过敏原挑战的上、下呼吸道嗜酸性炎症响应影响